Y Joseph Hwang1, Brian J Minnillo2, Simon P Kim3, Robert Abouassaly2. 1. Case Western Reserve University School of Medicine, Cleveland, OH; 2. Department of Urology, Case Western Reserve University School of Medicine, Cleveland, OH; ; Urology Institute, University Hospitals Case Medical Center, Cleveland, OH; 3. Department of Urology, Case Western Reserve University School of Medicine, Cleveland, OH; ; Urology Institute, University Hospitals Case Medical Center, Cleveland, OH; ; Yale University, Cancer Outcomes and Public Policy Effectiveness Research (COPPER) Center, New Haven, CT.
Abstract
INTRODUCTION: Length-of-stay (LOS), 30-day readmission, and 30-day mortality are metrics used to assess quality of care and provider reimbursement. Therefore, we investigated patient- and hospital-level characteristics associated with the three healthcare quality metrics for radical nephrectomy with inferior vena cava (IVC) thrombectomy. METHODS: Using the National Cancer Data Base, we established a cohort of patients who received radical nephrectomy following the diagnosis of renal cell carcinoma (RCC) stage cT3b between 1998 and 2011. We then assessed the associations between patient- or hospital-level characteristics and LOS using multivariable negative binomial regression. We used multivariable logistic regression to determine the associations between the characteristics and 30-day readmission or 30-day mortality. RESULTS: During the study period, 5768 patients were diagnosed with RCC stage cT3b and underwent radical nephrectomy. LOS ≤2 days and ≥9 days were associated with a higher likelihood of 30-day readmission (respective odds ratio [OR] 1.61 and 1.58) and 30-day mortality (respective OR 11.62 and 11.87). Older patients (60-79 years vs. <50 years) were less likely to experience 30-day readmission (OR 0.46-0.52). Older patients (≥80 years vs. <50 years, OR 3.67) and patients with a high index of comorbidity (Charlson comorbidity score ≥ 2 vs. 0, OR 1.95) were more likely to suffer 30-day mortality. CONCLUSIONS: LOS is an important predictor of short-term readmission and mortality following radical nephrectomy with IVC thrombectomy. Older age and a high index of comorbidity also predict short-term mortality after the surgery.
INTRODUCTION: Length-of-stay (LOS), 30-day readmission, and 30-day mortality are metrics used to assess quality of care and provider reimbursement. Therefore, we investigated patient- and hospital-level characteristics associated with the three healthcare quality metrics for radical nephrectomy with inferior vena cava (IVC) thrombectomy. METHODS: Using the National Cancer Data Base, we established a cohort of patients who received radical nephrectomy following the diagnosis of renal cell carcinoma (RCC) stage cT3b between 1998 and 2011. We then assessed the associations between patient- or hospital-level characteristics and LOS using multivariable negative binomial regression. We used multivariable logistic regression to determine the associations between the characteristics and 30-day readmission or 30-day mortality. RESULTS: During the study period, 5768 patients were diagnosed with RCC stage cT3b and underwent radical nephrectomy. LOS ≤2 days and ≥9 days were associated with a higher likelihood of 30-day readmission (respective odds ratio [OR] 1.61 and 1.58) and 30-day mortality (respective OR 11.62 and 11.87). Older patients (60-79 years vs. <50 years) were less likely to experience 30-day readmission (OR 0.46-0.52). Older patients (≥80 years vs. <50 years, OR 3.67) and patients with a high index of comorbidity (Charlson comorbidity score ≥ 2 vs. 0, OR 1.95) were more likely to suffer 30-day mortality. CONCLUSIONS: LOS is an important predictor of short-term readmission and mortality following radical nephrectomy with IVC thrombectomy. Older age and a high index of comorbidity also predict short-term mortality after the surgery.
Authors: C J Stimson; Sam S Chang; Daniel A Barocas; John E Humphrey; Sanjay G Patel; Peter E Clark; Joseph A Smith; Michael S Cookson Journal: J Urol Date: 2010-08-17 Impact factor: 7.450
Authors: Stanley A Yap; David Horovitz; Shabbir M H Alibhai; Robert Abouassaly; Narhari Timilshina; Antonio Finelli Journal: BJU Int Date: 2012-04-13 Impact factor: 5.588
Authors: Aksharananda Rambachan; Richard S Matulewicz; Matthew Pilecki; John Y S Kim; Shilajit D Kundu Journal: J Urol Date: 2014-02-08 Impact factor: 7.450
Authors: Deepak K Pruthi; Hanzhang Wang; Arpan Satsangi; Miguel Cajipe; Kevan Iffrig; Georges M Haidar; Taylor Hicks; Edward Y Sako; Michael A Liss; Wasim H Chowdhury; Ronald Rodriguez; Dharam Kaushik Journal: Can Urol Assoc J Date: 2018-05-14 Impact factor: 1.862
Authors: Donald E Fry; Michael Pine; Susan M Nedza; David G Locke; Agnes M Reband; Gregory Pine Journal: Medicine (Baltimore) Date: 2016-09 Impact factor: 1.889